TITLE

Efficacy of Tegaserod in Chronic Constipation in Men

AUTHOR(S)
Fried, Michael; Johanson, John F.; Gwee, Kok Ann; Wagner, Amy; Pecher, Eckhard; Rueegg, Peter
PUB. DATE
February 2007
SOURCE
American Journal of Gastroenterology;Feb2007, Vol. 102 Issue 2, p362
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES: Chronic constipation/idiopathic constipation is highly prevalent in western countries and traditional treatments are suboptimal. This multicenter study evaluated the efficacy and safety of tegaserod, a selective 5-HT4 agonist and promotility agent, in men with chronic constipation. METHODS: After screening and baseline phases, men with chronic constipation were randomized to receive either tegaserod 6 mg twice daily or placebo in a double-blind manner for 12 wk. Patients recorded symptoms using a diary. Primary efficacy variable was the response rate for an increase in complete spontaneous bowel movements (CSBMs) during the first 4 wk of double-blind treatment. Other efficacy measures included patient assessment of symptoms and satisfaction with symptom relief. Safety and tolerability were also evaluated. RESULTS: In total, 322 patients were randomized to tegaserod (N = 158) or placebo (N = 164). Increases of at least one CSBM per wk during the first 4 wk of treatment observed for tegaserod compared with placebo (40.5% vs 29.3%, P= 0.03) were sustained throughout the 12-wk treatment period. Response rate for CSBM was also superior for tegaserod ( P= 0.04 vs placebo) over the treatment period. Benefits for tegaserod over placebo were also observed for some secondary efficacy variables, however, statistical significance was not achieved at all weeks. Frequency of adverse events was similar with tegaserod and placebo. CONCLUSIONS: Tegaserod 6 mg twice daily was effective and well tolerated in the treatment of chronic constipation in men. Tegaserod provided rapid relief of constipation within 1 wk and the effects were sustained for up to 12 wk.
ACCESSION #
23774278

 

Related Articles

  • Penicillin for acute sore throat in children: randomised, double blind trial. Zwart, Sjoerd; Rovers, Maroeska M.; de Melker, Ruut A.; Hoes, Arno W. // BMJ: British Medical Journal (International Edition);12/6/2003, Vol. 327 Issue 7427, p1324 

    Abstract Objective: To assess the effectiveness of penicillin for three days and treatment for seven days compared with placebo in resolving symptoms in children with sore throat. Design: Randomised, double blind, placebo controlled trial. Setting: 43 family practices in the Netherlands....

  • Atomoxetine in the Management of Children with ADHD: Effects on Quality of Life and School Functioning. Brown, Ronald T.; Perwien, Amy; Faries, Douglas E.; Kratochvil, Christopher J.; Vaughan, Brigette S. // Clinical Pediatrics;Nov2006, Vol. 45 Issue 9, p819 

    The purpose of this study was to examine in a controlled trial the effects of atomoxetine on the management of attention deficit-hyperactivity disorder (ADHD) symptoms and functional impairments at school and at home. Participants were 153 children (age 8 to 12 years) diagnosed with...

  • Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. Aveyard, Paul; Johnson, Carol; Fillingham, Sally; Parsons, Amanda; Murphy, Mike // BMJ: British Medical Journal (International Edition);5/31/2008, Vol. 336 Issue 7655, p1223 

    Objective To test the efficacy of nortriptyline plus nicotine replacement therapy compared with placebo plus nicotine replacement therapy for smoking cessation. Design Pragmatic randomised controlled trial. Setting National Health Service stop smoking service clinics. Participants 901 people...

  • Efficacy of segmental stabilization exercise for lumbar segmental instability in patients with mechanical low back pain: A randomized placebo controlled crossover study. Kumar, Senthil P. // North American Journal of Medical Sciences;Oct2011, Vol. 3 Issue 10, p456 

    Background: Lumbar segmental stability is an important biomechanical component that influences symptoms amongst patients with Mechanical low back pain. Aims: To compare the efficacy of segmental stabilization exercises utilizing multifidus and transversus abdominis muscles versus a placebo...

  • Apixaban zur Behandlung einer akuten venösen Thromboembolie. Steurer, Johann // Praxis (16618157);10/30/2013, Vol. 102 Issue 22, p1387 

    No abstract available.

  • A double-bind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia. Downing, AnnCatherine M.; Kinon, Bruce J.; Millen, Brian A.; Lu Zhang; Lin Liu; Morozova, Margarita A.; Brenner, Ronald; Rayle, Tami Jo; Nisenbaum, Laura; Fangyi Zhao; Gomez, Juan Carlos // BMC Psychiatry;2014, Vol. 14 Issue 1, p1 

    Background Pomaglumetad methionil (LY2140023 monohydrate) is a potent and highly selective agonist for the metabotropic glutamate mGluR2 and mGluR3 receptors. We present results of a pivotal clinical study H8Y-MC-HBBM assessing the efficacy of LY2140023 in improving symptoms as a monotherapy in...

  • Effect of pharmacotherapy for anxiety disorders on quality of life: a meta-analysis. Hofmann, Stefan; Wu, Jade; Boettcher, Hannah; Sturm, Jamie // Quality of Life Research;May2014, Vol. 23 Issue 4, p1141 

    Purpose: Pharmacotherapy is an effective treatment for anxiety disorders, but its effects on quality of life (QOL) have not been examined systematically. Our objective was to conduct an effect size analysis of pharmacological interventions on QOL outcomes in patients with DSM-IV anxiety...

  • The significance of early treatment of exudative age-related macular degeneration: 12 months' results. Weingessel, Birgit; Hintermayer, Gregor; Maca, Saskia M.; Rauch, Renate; Vecsei-Marlovits, Pia Veronika // Wiener Klinische Wochenschrift;Nov2012, Vol. 124 Issue 21/22, p750 

    Background: To assess whether the period between initial symptoms and therapy with ranibizumab in patients with choroidal neovascularization (CNV) influences visual outcome after a follow-up of 12 months. Methods: Fifty patients with CNV were retrospectively split into three groups depending on...

  • ACAT Inhibition and Progression of Carotid Atherosclerosis in Patients With Familial Hypercholesterolemia. Meuwese, Marijn C.; de Groot, Eric; Duivenvoorden, Raphaël; Trip, Mieke D.; Ose, Leiv; Maritz, Frans J.; Basart, Dick C. G.; Kastelein, John J. P.; Habib, Rafik; Davidson, Michael H.; Zwinderman, Aeilko H.; Schwocho, Lee R.; Stein, Evan A. // JAMA: Journal of the American Medical Association;3/18/2009, Vol. 301 Issue 11, p1131 

    The article reports on the results of research which was conducted in an effort to evaluate the efficacy and safety of pactimibe in the inhibition of carotid atherosclerosis in patients with familial history of hypercholesterolemia. researchers conducted a prospective, randomized, stratified,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics